Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Pharmacological Treatment of Parkinson’s Disease

In: Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018 Dec 21. Chapter 7.
Affiliations
Free Books & Documents
Review

Pharmacological Treatment of Parkinson’s Disease

Insha Zahoor et al.
Free Books & Documents

Excerpt

Parkinson’s disease (PD) is one of the common chronic degenerative conditions of the nervous system. There is currently no cure for PD, but a number of drugs offer benefits in terms of controlling the motor symptoms. While these drugs can offer significant improvements to motor function, they may lead to problematic adverse effects, particularly as disease progresses. In this chapter, we focus on the drugs that are currently employed for the treatment of PD, including discussion on their mode of action, clinical utility, and adverse effects. We also cover some interesting emerging approaches that are currently under investigation.

PubMed Disclaimer

References

    1. Jankovic J. Parkinson’s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–76. doi: 10.1136/jnnp.2007.131045. - DOI - PubMed
    1. Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet. 2004;363(9423):1783–93. doi: 10.1016/S0140-6736(04)16305-8. - DOI - PubMed
    1. Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016;139 Suppl 1:318–24. doi: 10.1111/jnc.13691. - DOI - PubMed
    1. AlDakheel A, Kalia LV, Lang AE. Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics. 2014;11(1):6–23. doi: 10.1007/s13311-013-0218-1. - DOI - PMC - PubMed
    1. Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: A review. JAMA. 2014;311(16):1670–83. doi: 10.1001/jama.2014.3654. - DOI - PubMed

LinkOut - more resources